AbbVie seeks approval for upadacitinib to treat nr-axSpA
Abbvie has submitted applications to the US FDA and the EMA to obtain approvals for upadacitinib (RINVOQ) to treat nr-axSpA.
Page 3 - End Third Level News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from End Third Level. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In End Third Level Today - Breaking & Trending Today
Gerresheimer AG extends CEO Dietmar Siemssen's Contract by Five Years - Pharmaceutical Business review
At its meeting yesterday, the Supervisory Board of Gerresheimer AG extended the contract with CEO Dietmar Siemssen to the end of October 2026. Dietmar Siemssen has been CEO
Roche gets FDA breakthrough therapy for tiragolumab PD-L1-high NSCLC
Roche has secured breakthrough therapy designation from the US FDA for tiragolumab plus Tecentriq as a first-line treatment for people with NSCLC whose